Article
miR-455 Inhibits the Viability and Invasion by Targeting RAB18 in Hepatocellular Carcinoma
Journal of Oncology · 2021 · Chenghong Wang, author Guicai Zhu, author Miaolin Yu, author Xiufang Mi, author Honghua Qu, author Alamgeer Yuchi, Academic Editor
Key facts
| Title | miR-455 Inhibits the Viability and Invasion by Targeting RAB18 in Hepatocellular Carcinoma |
|---|---|
| First author | Chenghong Wang, author Guicai Zhu, author Miaolin Yu, author Xiufang Mi, author Honghua Qu, author Alamgeer Yuchi, Academic Editor |
| Journal | Journal of Oncology |
| Published | Mar 29, 2021 |
| DOI | 10.1155/2021/9923454 |
| Product codes mentioned | CEK |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1